At this time, posts about Neofect are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net purchased 53,000 shares today.


As of 11:30 AM on the 28th, Neofect's stock price is 5,070 KRW, up 4.21% from the previous day, with a trading volume of 7,137,679 shares, which is 1,071.29% of the 5-day average trading volume. On September 25, Neofect became a market issue with the news of completing Phase 3 clinical trials for depression home treatment.


In addition to Neofect, posts by investors are also rapidly increasing for Daishin Information & Communications (020180), East Asia Holdings (900110), and Crucialtec (114120).



※ Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing